The role of D2-autoreceptors in regulating dopamine neuron activity and transmission
- PMID: 24463000
- PMCID: PMC4108583
- DOI: 10.1016/j.neuroscience.2014.01.025
The role of D2-autoreceptors in regulating dopamine neuron activity and transmission
Abstract
Dopamine D2-autoreceptors play a key role in regulating the activity of dopamine neurons and control the synthesis, release and uptake of dopamine. These Gi/o-coupled inhibitory receptors play a major part in shaping dopamine transmission. Found at both somatodendritic and axonal sites, autoreceptors regulate the firing patterns of dopamine neurons and control the timing and amount of dopamine released from their terminals in target regions. Alterations in the expression and activity of autoreceptors are thought to contribute to Parkinson's disease as well as schizophrenia, drug addiction and attention-deficit hyperactivity disorder (ADHD), which emphasizes the importance of D2-autoreceptors in regulating the dopamine system. This review will summarize the cellular actions of dopamine autoreceptors and discuss recent advances that have furthered our understanding of the mechanisms by which D2-receptors control dopamine transmission.
Keywords: GPCR; VTA; cocaine; psychostimulants; substantia nigra.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.Brain. 2014 Aug;137(Pt 8):2287-302. doi: 10.1093/brain/awu131. Epub 2014 Jun 16. Brain. 2014. PMID: 24934288 Free PMC article.
-
Amphetamine self-administration attenuates dopamine D2 autoreceptor function.Neuropsychopharmacology. 2014 Jul;39(8):1833-42. doi: 10.1038/npp.2014.30. Epub 2014 Feb 11. Neuropsychopharmacology. 2014. PMID: 24513972 Free PMC article.
-
Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function.BMC Neurosci. 2009 Aug 14;10:96. doi: 10.1186/1471-2202-10-96. BMC Neurosci. 2009. PMID: 19682375 Free PMC article.
-
Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.Pharmacol Ther. 2020 Sep;213:107583. doi: 10.1016/j.pharmthera.2020.107583. Epub 2020 May 27. Pharmacol Ther. 2020. PMID: 32473160 Free PMC article. Review.
-
Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.J Neurosci. 1998 Mar 15;18(6):2231-8. doi: 10.1523/JNEUROSCI.18-06-02231.1998. J Neurosci. 1998. PMID: 9482807 Free PMC article. Review.
Cited by
-
Kappa Opioid Receptors Negatively Regulate Real Time Spontaneous Dopamine Signals by Reducing Release and Increasing Uptake.bioRxiv [Preprint]. 2024 Feb 6:2024.02.05.578840. doi: 10.1101/2024.02.05.578840. bioRxiv. 2024. PMID: 38370660 Free PMC article. Preprint.
-
Initial Molecular Mechanisms of the Pathogenesis of Parkinson's Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease.Int J Mol Sci. 2024 Jan 22;25(2):1354. doi: 10.3390/ijms25021354. Int J Mol Sci. 2024. PMID: 38279354 Free PMC article.
-
PI4KIIIβ-Mediated Phosphoinositides Metabolism Regulates Function of the VTA Dopaminergic Neurons and Depression-Like Behavior.J Neurosci. 2024 Mar 13;44(11):e0555232024. doi: 10.1523/JNEUROSCI.0555-23.2024. J Neurosci. 2024. PMID: 38267258
-
Decoupling Dopamine Synthesis from Impulsive Action, Risk-Related Decision-Making, and Propensity to Cocaine Intake: A Longitudinal [18F]-FDOPA PET Study in Roman High- and Low-Avoidance Rats.eNeuro. 2024 Feb 14;11(2):ENEURO.0492-23.2023. doi: 10.1523/ENEURO.0492-23.2023. Print 2024 Feb. eNeuro. 2024. PMID: 38253584 Free PMC article.
-
The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions.J Exp Clin Cancer Res. 2024 Jan 22;43(1):25. doi: 10.1186/s13046-024-02947-7. J Exp Clin Cancer Res. 2024. PMID: 38246990 Free PMC article.
References
-
- Adell A, Artigas F. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev. 2004;28:415–431. - PubMed
-
- Aghajanian GK, Bunney BS. Dopamine “autoreceptors”: pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol. 1977;297:1–7. - PubMed
-
- Anzalone A, Lizardi-Ortiz JE, Ramos M, De Mei C, Hopf FW, Iaccarino C, Halbout B, Jacobsen J, Kinoshita C, Welter M, Caron MG, Bonci A, Sulzer D, Borrelli E. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci. 2012;32:9023–9034. - PMC - PubMed
-
- Baik JH, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, Le Meur M, Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 1995;377:424–428. - PubMed
-
- Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63:182–217. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
